Since 1997, the Centers for Disease Control and Prevention (CDC) has collaborated with numerous partners to develop and chart the course of the multidisciplinary field of public health genomics in the USA and globally. During this period, CDC has developed major initiatives for the appropriate integration of genomics into public health research, policy and programs. In this paper, we review briefly the progress in public health genomics made over the past decade in the USA, including population research, the human genome epidemiology network (HuGENetTM), the evaluation of genomic applications in practice and prevention (EGAPP), the family history public health initiative, and efforts in building the public health genomics capacity. We also outline a vision for public health genomics for the next decade.

Keywords:
Epidemiology, Genetics, Genomics, Public health
1.
Centers for Disease Control and Prevention. The National Office of Public Health Genomics. http://www.cdc.gov/genomics/ (accessed online January 2, 2008).
2.
Burke W, Khoury MJ, Stewart A, Zimmern RL, Bellagio Group: The path from genome-based research to population health: development of an international public health genomics network. Genet Med 2006;8:451–458.
3.
Zerhouni E: NIH Press release: NIH seeks input on proposed repository for genetic information. August 30, 2006. http://www.nih.gov/news/pr/aug2006/od-30.htm (accessed online September 1, 2006).
4.
Amplichip homepage. http://www.amplichip.us/ (accessed online January 2, 2008).
5.
Levy S, Sutton G, Ng PC, Feuk L, Halpern AL, Walenz BP, Axelrod N, Huang J, Kirkness EF, Denisov G, Lin Y, MacDonald JR, Pang AW, Shago M, Stockwell TB, Tsiamouri A, Bafna V, Bansal V, Kravitz SA, Busam DA, Beeson KY, McIntosh TC, Remington KA, Abril JF, Gill J, Borman J, Rogers YH, Frazier ME, Scherer SW, Strausberg RL, Venter JC: The diploid genome sequence of an individual human. PLoS Biol 2007;5:e254.
6.
Chaufan C: How much can a large population study on genes, environments, their interactions and common diseases contribute to the health of the American people? Soc Sci Med 2007;65:1730–1741.
7.
Buchanan AV, Weiss KM, Fullerton SM: Dissecting complex disease: the quest for the philosopher’s stone? Int J Epidemiol 2006;35:562–571.
8.
Holtzman NA: What role for public health in genetics and vice versa? Community Genet 2006;9:8–20.
9.
Rockhill B: Theorizing about causes at the individual level while estimating effects at the population level: implications for prevention. Epidemiology 2005;16:124–129.
10.
Rose G: Sick individuals and sick populations. Int J Epidemiol 1985;14:32–38.
11.
Khoury MJ, Gwinn M, Burke W, Bowen MS, Zimmern RL: Will genomics widen or help heal the schism between medicine and public health? Am J Prev Med 2007;33:310–317.
12.
Khoury MJ, Gwinn M, Yoon PW, Dowling N, Moore CA, Bradley C: The continuum of translation research in genomic medicine: how can we accelerate the appropriate integration of human genome discoveries into health care and disease prevention? Genet Med 2007;9:665–674.
13.
Chang MH, Lindegren ML, Moore C, Khoury MJ: Prevalence in genetic variants of public health significance in the United States. Am J Epidemiol, submitted.
14.
Davey Smith G, Ebrahim S: ‘Mendelian randomization’: can genetic epidemiology contribute to understanding environmental determinants of disease? Int J Epidemiol 2003;32:1–22.
15.
Khoury MJ, Davis RL, Gwinn M, Lindegren ML, Yoon PW: Do we need genomic research for the prevention of common diseases with environmental causes? Am J Epidemiol 2005;161:799–805.
16.
CDC National Office of Public Health Genomics. http://www.cdc.gov/genomics/activities/fund2006.htm (accessed online January 2, 2008).
17.
The Human Genome Epidemiology Network (HuGENet). http://www.cdc.gov/genomics/hugenet/default.htm (accessed online January 2, 2008).
18.
Ioannidis JP, Bernstein J, Boffetta P, Danesh J, Dolan S, Hartge P, Hunter D, Inskip P, Jarvelin MR, Little J, Maraganore DM, Bishop JA, O’Brien TR, Petersen G, Riboli E, Seminara D, Taioli E, Uitterlinden AG, Vineis P, Winn DM, Salanti G, Higgins JP, Khoury MJ: A network of investigator networks in human genome epidemiology. Am J Epidemiol 2005;162:302–304.
19.
Ioannidis JP, Gwinn M, Little J, Higgins JP, Bernstein JL, Boffetta P, Bondy M, Bray MS, Brenchley PE, Buffler PA, Casas JP, Chokkalingam A, Danesh J, Smith GD, Dolan S, Duncan R, Gruis NA, Hartge P, Hashibe M, Hunter DJ, Jarvelin MR, Malmer B, Maraganore DM, Newton-Bishop JA, O’Brien TR, Petersen G, Riboli E, Salanti G, Seminara D, Smeeth L, Taioli E, Timpson N, Uitterlinden AG, Vineis P, Wareham N, Winn DM, Zimmern R, Khoury MJ: A road map for efficient and reliable human genome epidemiology. Nat Genet 2006;38:3–5.
20.
HuGENet workshop. Strengthening the reporting of genetic associations (STREGA). Manuscript in preparation. Details on workshop available at http://www.cdc.gov/genomics/hugenet/strega.htm.
21.
Ioannidis JP, Boffetta P, Little J, O’Brien TR, Uitterlinden AG, Vineis P, Balding DJ, Chokkalingam A, Dolan SM, Flanders WD, Higgins JP, McCarthy MI, McDermott DH, Page GP, Rebbeck TR, Seminara D, Khoury MJ: Assessment of cumulative evidence on genetic associations: interim guidelines. Int J Epidemiol 2008;37:120–132.
22.
Evaluation of Genomic Applications in Practice and Prevention (EGAPP). http://www.egappreviews.org/ (accessed online January 2, 2008).
23.
Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Working Group. Recommendations from the EGAPP Working Group: Testing for cytochrome P450 polymorphisms in adults with nonpsychotic depression treated with selective serotonin reuptake inhibitors. Genet Med 2007;9:819–825.
24.
CDC National Office of Public Health Genomics: Family history public health initiative. http://www.cdc.gov/genomics/activities/famhx.htm (accessed online January 2, 2008).
25.
Yoon PW, Scheuner MT, Khoury MJ: Research priorities for evaluating family history in the prevention of common chronic diseases. Am J Prev Med 2003;24:128–135.
26.
CDC National Office of Public Health Genomics: Genomics competencies for the public health workforce. http://www.cdc.gov/genomics/training/competencies/default.htm (accessed online January 2, 2008).
27.
CDC National Office of Public Health Genomics: Centers for genomics and public health. http://www.cdc.gov/genomics/activities/fund2005.htm (accessed online January 2, 2008).
28.
CDC National Office of Public Health Genomics: Developing state capacity for integrating genomics into chronic disease programs. http://www.cdc.gov/genomics/activities/ogdp/2005/chap10.htm (accessed online January 2, 2008).
29.
Goddard KAB, Moore C, Ottman D, Bradley L, Khoury MJ: Awareness and use of direct-to-consumer nutrigenomic tests, United States, 2006. Genet Med 2007;9:510–517.
30.
Jannssens AC, Gwinn M, Bradley LA, Oostra BA, van Dujin CM, Khoury MJ: A critical appraisal of the scientific basis of commercial genomic profiles used to assess health risks and personalize health interventions. Am J Hum Genet 2008;82:593–595.
31.
Hunter D, Khoury MJ, Drazen J: Letting the genome out of the bottle – will we get our wish? New Engl J Med 2008;358:105–107.
32.
CDC National Office of Public Health Genomics: Genomics applications in practice and prevention translation research. Funding announcement. http://www07.grants.gov/search/search.do;jsessionid=HLHJnKsTGktmyTnSm9B1vv4W3VVQR1T2Td 2FDTVR3nHZbXyFyyHt!-1797286335?oppId=16029&flag2006=true&mode=VIEW (accessed online January 2, 2008).
33.
Waalen J, Beutler E: Hereditary hemochromatosis. Screening and management. Curr Hematol Rep 2006;5:34–40.
34.
MED PED (Make Early Diagnosis Prevent Early Deaths) website. http://www.medped.org/ (accessed online January 2, 2008).
35.
Modell Foundation: 10 warning signs for primary immune deficiency disorders. http://www.info4pi.org/patienttopatient/index.cfm?section=patienttopatient&content=warningsigns (accessed online January 2, 2008).
© 2008 S. Karger AG, Basel
2008
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.